home / stock / negxf / negxf quote
Last: | $0.20 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.20 |
High: | $0 |
Low: | $0 |
Volume: | 25,000 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.2 | $0 | $0.2 | $0 | $0 | 25,000 | 03-19-2024 |
$0.2 | $0.2 | $0.2 | $0.2 | $0.2 | 8,000 | 02-20-2024 |
$0.1804 | $0 | $0.1804 | $0 | $0 | 4,500 | 01-05-2024 |
$0.1804 | $0.1767 | $0.1804 | $0.1804 | $0.1767 | 5,500 | 01-02-2024 |
$0.194 | $0 | $0.194 | $0 | $0 | 600 | 11-21-2023 |
$0.194 | $0 | $0.194 | $0 | $0 | 3,400 | 10-25-2023 |
$0.194 | $0.194 | $0.194 | $0.194 | $0.194 | 100 | 10-23-2023 |
$0.1933 | $0.1933 | $0.1933 | $0.1933 | $0.1933 | 600 | 10-19-2023 |
$0.211 | $0 | $0.211 | $0 | $0 | 400 | 10-04-2023 |
$0.211 | $0.211 | $0.211 | $0.211 | $0.211 | 300 | 08-30-2023 |
$0.2437 | $0 | $0.2437 | $0 | $0 | 8,000 | 05-24-2023 |
$0.2437 | $0.2437 | $0.2437 | $0.2437 | $0.2437 | 150 | 04-14-2023 |
$0.2417 | $0.2417 | $0.2417 | $0.2417 | $0.2417 | 100 | 04-12-2023 |
$0.2569 | $0.2569 | $0.2569 | $0.2569 | $0.2569 | 125 | 04-05-2023 |
$0.2021 | $0 | $0.2021 | $0 | $0 | 30 | 03-06-2023 |
$0.2021 | $0 | $0.2021 | $0 | $0 | 100 | 03-03-2023 |
$0.2021 | $0.2022 | $0.2021 | $0.2022 | $0.2021 | 16,000 | 12-05-2022 |
$0.011 | $0.011 | $0.011 | $0.011 | $0.011 | 400 | 09-27-2022 |
$0.2495 | $0.2495 | $0.2495 | $0.2495 | $0.2495 | 200 | 09-26-2022 |
$0.2747 | $0 | $0.2747 | $0 | $0 | 200 | 09-23-2022 |
News, Short Squeeze, Breakout and More Instantly...
TORONTO, ON / ACCESSWIRE / April 5, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its annual financial results for the financial year ended December 31, 2023, with continued revenue growth to $3,573,751 for the quarter and $13,846,329 year to date. Annual EBITDA was $...
TORONTO, ON / ACCESSWIRE / December 20, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been declared in respect of all of its outstanding common shares and series 1 preferred shares. This divi...
TORONTO, ON / ACCESSWIRE / November 23, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its interim financial results for the third quarter ended September 30, 2023, with continued revenue growth to $3,390,174 for the quarter and $10,272,578 year to date. The quarterl...